The Biotech Growth Trust PLC Cash Flow Conversion Efficiency

Latest as of September 2025: -0.010x

The Biotech Growth Trust PLC cash flow conversion efficiency. Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) has a cash flow conversion efficiency ratio of -0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.52 Million ≈ $-306.25 USD) by net assets (GBX257.88 Million ≈ $31.38K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of The Biotech Growth Trust PLC (2012–2025)

Cash flow conversion efficiency of The Biotech Growth Trust PLC from 2012 to 2025. This chart illustrates how The Biotech Growth Trust PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BIOG stock price for real-time trading data and today's change.

The Biotech Growth Trust PLC Cash Flow Conversion Ratio Explained

The Biotech Growth Trust PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

The Biotech Growth Trust PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of The Biotech Growth Trust PLC ranked by their cash flow conversion efficiency. Also see The Biotech Growth Trust PLC (BIOG) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Odd Burger Corp V:ODD	0.012x
Bioter S.A. AT:BIOT	0.009x
ZW Data Action Technologies Inc NASDAQ:CNET	-0.026x
Zaplox AB ST:ZAPLOX	25.961x
Love Group Global Ltd AU:LVE	0.677x
Aeeris Ltd AU:AER	-0.227x
H&T Group plc LSE:HAT	0.033x
Kuniko Ltd AU:KNI	-0.069x

Annual Cash Flow Conversion Efficiency for The Biotech Growth Trust PLC (2012–2025)

The table below shows the annual cash flow conversion efficiency of The Biotech Growth Trust PLC from 2012 to 2025. Review BIOG free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX221.21 Million ≈ $26.91K	GBX-5.09 Million ≈ $-618.94	-0.023x	-95.92%
2024-03-31	GBX361.31 Million ≈ $43.96K	GBX-4.24 Million ≈ $-516.01	-0.012x	+34.18%
2023-03-31	GBX330.29 Million ≈ $40.19K	GBX-5.89 Million ≈ $-716.64	-0.018x	+42.10%
2022-03-31	GBX394.21 Million ≈ $47.96K	GBX-12.14 Million ≈ $-1.48K	-0.031x	-226.48%
2021-03-31	GBX601.47 Million ≈ $73.18K	GBX-5.67 Million ≈ $-690.36	-0.009x	+8.40%
2020-03-31	GBX365.57 Million ≈ $44.48K	GBX-3.77 Million ≈ $-458.09	-0.010x	+4.27%
2019-03-31	GBX408.88 Million ≈ $49.75K	GBX-4.40 Million ≈ $-535.23	-0.011x	-9.39%
2018-03-31	GBX417.40 Million ≈ $50.79K	GBX-4.11 Million ≈ $-499.46	-0.010x	+16.56%
2017-03-31	GBX448.41 Million ≈ $54.56K	GBX-5.29 Million ≈ $-643.03	-0.012x	+24.47%
2016-03-31	GBX378.57 Million ≈ $46.06K	GBX-5.91 Million ≈ $-718.71	-0.016x	-1283.70%
2015-03-31	GBX533.30 Million ≈ $64.89K	GBX703.00K ≈ $85.53	0.001x	+100.86%
2014-03-31	GBX340.25 Million ≈ $41.40K	GBX-52.25 Million ≈ $-6.36K	-0.154x	-3352.62%
2013-03-31	GBX244.44 Million ≈ $29.74K	GBX1.15 Million ≈ $140.41	0.005x	+267.90%
2012-03-31	GBX156.13 Million ≈ $19.00K	GBX-439.00K ≈ $-53.41	-0.003x	--

About The Biotech Growth Trust PLC

LSE:BIOG UK Asset Management

Market Cap

$3.44 Million

GBX28.30 Billion GBX

Market Cap Rank

#29209 Global

#561 in UK

Share Price

GBX1364.00

Change (1 day)

-1.30%

52-Week Range

GBX1065.00 - GBX1768.00

All Time High

GBX1768.00